IBDEI0YT ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15719,1,4,0)
 ;;=4^I25.708
 ;;^UTILITY(U,$J,358.3,15719,2)
 ;;=^5007119
 ;;^UTILITY(U,$J,358.3,15720,0)
 ;;=I25.709^^61^763^20
 ;;^UTILITY(U,$J,358.3,15720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15720,1,3,0)
 ;;=3^Athscl of CABG,Unspec w/ Unspec Angina Pectoris
 ;;^UTILITY(U,$J,358.3,15720,1,4,0)
 ;;=4^I25.709
 ;;^UTILITY(U,$J,358.3,15720,2)
 ;;=^5007120
 ;;^UTILITY(U,$J,358.3,15721,0)
 ;;=I25.700^^61^763^21
 ;;^UTILITY(U,$J,358.3,15721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15721,1,3,0)
 ;;=3^Athscl of CABG,Unspec w/ Unstable Angina Pectoris
 ;;^UTILITY(U,$J,358.3,15721,1,4,0)
 ;;=4^I25.700
 ;;^UTILITY(U,$J,358.3,15721,2)
 ;;=^5007117
 ;;^UTILITY(U,$J,358.3,15722,0)
 ;;=I82.469^^61^763^24
 ;;^UTILITY(U,$J,358.3,15722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15722,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Calf Muscle Vein,Acute
 ;;^UTILITY(U,$J,358.3,15722,1,4,0)
 ;;=4^I82.469
 ;;^UTILITY(U,$J,358.3,15722,2)
 ;;=^5158066
 ;;^UTILITY(U,$J,358.3,15723,0)
 ;;=I82.569^^61^763^25
 ;;^UTILITY(U,$J,358.3,15723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15723,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Calf Muscle Vein,Chronic
 ;;^UTILITY(U,$J,358.3,15723,1,4,0)
 ;;=4^I82.569
 ;;^UTILITY(U,$J,358.3,15723,2)
 ;;=^5158074
 ;;^UTILITY(U,$J,358.3,15724,0)
 ;;=I80.259^^61^763^33
 ;;^UTILITY(U,$J,358.3,15724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15724,1,3,0)
 ;;=3^Phlebitis & Thrombophlebitis,Unspec Calf Muscle Vein
 ;;^UTILITY(U,$J,358.3,15724,1,4,0)
 ;;=4^I80.259
 ;;^UTILITY(U,$J,358.3,15724,2)
 ;;=^5158058
 ;;^UTILITY(U,$J,358.3,15725,0)
 ;;=I82.409^^61^763^26
 ;;^UTILITY(U,$J,358.3,15725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15725,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Acute
 ;;^UTILITY(U,$J,358.3,15725,1,4,0)
 ;;=4^I82.409
 ;;^UTILITY(U,$J,358.3,15725,2)
 ;;=^5133625
 ;;^UTILITY(U,$J,358.3,15726,0)
 ;;=I82.509^^61^763^27
 ;;^UTILITY(U,$J,358.3,15726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15726,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Chronic
 ;;^UTILITY(U,$J,358.3,15726,1,4,0)
 ;;=4^I82.509
 ;;^UTILITY(U,$J,358.3,15726,2)
 ;;=^5133628
 ;;^UTILITY(U,$J,358.3,15727,0)
 ;;=E78.1^^61^764^23
 ;;^UTILITY(U,$J,358.3,15727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15727,1,3,0)
 ;;=3^Pure Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,15727,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,15727,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,15728,0)
 ;;=E78.2^^61^764^21
 ;;^UTILITY(U,$J,358.3,15728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15728,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,15728,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,15728,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,15729,0)
 ;;=I10.^^61^764^9
 ;;^UTILITY(U,$J,358.3,15729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15729,1,3,0)
 ;;=3^Essential Primary Hypertension
 ;;^UTILITY(U,$J,358.3,15729,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,15729,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,15730,0)
 ;;=I11.9^^61^764^19
 ;;^UTILITY(U,$J,358.3,15730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15730,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,15730,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,15730,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,15731,0)
 ;;=I11.0^^61^764^18
 ;;^UTILITY(U,$J,358.3,15731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15731,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
